0 Bewertungen0% fanden dieses Dokument nützlich (0 Abstimmungen)
64 Ansichten5 Seiten
The document provides guidance on caring for HIV-exposed infants, including providing antiretroviral prophylaxis like nevirapine syrup once daily for 6 weeks for infants of mothers receiving ART and breastfeeding. It also recommends cotrimoxazole starting at 6 weeks to prevent opportunistic infections, continuing until the infant's HIV status is determined after breastfeeding ends, as well as immunizations and routine monitoring until the infant's status is known.
The document provides guidance on caring for HIV-exposed infants, including providing antiretroviral prophylaxis like nevirapine syrup once daily for 6 weeks for infants of mothers receiving ART and breastfeeding. It also recommends cotrimoxazole starting at 6 weeks to prevent opportunistic infections, continuing until the infant's HIV status is determined after breastfeeding ends, as well as immunizations and routine monitoring until the infant's status is known.
The document provides guidance on caring for HIV-exposed infants, including providing antiretroviral prophylaxis like nevirapine syrup once daily for 6 weeks for infants of mothers receiving ART and breastfeeding. It also recommends cotrimoxazole starting at 6 weeks to prevent opportunistic infections, continuing until the infant's HIV status is determined after breastfeeding ends, as well as immunizations and routine monitoring until the infant's status is known.
PMTCT Inspector/HIV Dept Focal Point, Ministry of Health, Juba Care of HIV-Exposed Infants • antiretroviral (ARV) prophylaxis, • cotrimoxazole (CTX) prophylaxis • Immunizations, and • Routine monitoring of the infant until determination of HIV infection status takes place NVP Prophylaxis for HIV-Exposed Infants • Infants of mothers who are receiving ART and breast feeding should receive 6 weeks of • NVP syrup is given once daily Cotrimoxazole for HIV-Exposed Infants • Cotrimoxazole can prevent infections like malaria, pneumonia, and some kinds of diarrhoea. It is safe and has few side effects. • At 6 weeks HIV-exposed infants should be started on cotrimoxazole to prevent opportunistic infections. • Continue cotrimoxazole until a definitive diagnosis is obtained after breastfeeding has stopped. • If the infant is determined to be HIV infected he should stay on the medication.